Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

LEO 29102 Single and Multiple Dose Study by Dermal Application

This study has been completed.
Information provided by (Responsible Party):
LEO Pharma Identifier:
First received: April 30, 2009
Last updated: March 2, 2016
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)